Elisabeth Gatineau

Elisabeth Gatineau currently serves as Principal Medical Writer at Sobi - Swedish Orphan Biovitrum AB (publ) since January 2024. Prior to this role, Elisabeth held the position of Associate Director - Expert Regulatory Writer at Idorsia Pharmaceuticals Ltd from January 2020 to December 2023. Elisabeth's extensive experience at Novartis spanned from 2000 to 2020, where various roles included Senior Regulatory Writer, Expert Medical Writer, Senior Medical Writer, Senior Publishing Scientist, and Project Manager. Earlier, Elisabeth was a Regulatory Affairs Manager at Novartis France from 1997 to 2000. Elisabeth Gatineau holds a Master's degree in Pharmaceutical Sciences from Université Claude Bernard Lyon 1, a Master's degree in Industrial and Physical Pharmacy and Cosmetic Sciences from Paris-Sud University (Paris XI), and a Bachelor of Science in Analytical Chemistry from Paris-Sud University (Paris XI).